Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Christopher Morris

Newcastle AuthorsTitleYearFull text
Dr Clare Tweedy
Nathan Kindred
Professor John-Paul Taylor
Dr Daniel Erskine
Dr Christopher Morris
et al.		Hippocampal network hyperexcitability in young transgenic mice expressing human mutant alpha-synuclein2021
Dr Michael Keogh
Dr Christopher Morris
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity2020
Dr Christopher Morris
Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia2020
Dr Daniel Erskine
Dr Christopher Morris
Professor Johannes Attems
Investigating the Presence of Doubly‐phosphorylated α‐Synuclein at Tyrosine 125 and Serine 129 In Idiopathic Lewy Body Diseases2020
Dr Christopher Morris
Label-Free Nanoimaging of Neuromelanin in the Brain by Soft X-ray Spectromicroscopy2020
Dr Marzena Kurzawa-Akanbi
Dr Michael Keogh
Eliona Tsefou
Lynne Ramsay
Mary Johnson
et al.		Neuropathological and Biochemical Investigation of Hereditary Ferritinopathycases With Ferritin Light Chain Mutation: Prominent Protein Aggregation in the Absence of Major Mitochondrial or Oxidative Stress2020
Professor Alan Thomas
Dr Calum Hamilton
Dr Paul Donaghy
Dr Carmen Martin-Ruiz
Dr Christopher Morris
et al.		Prospective Longitudinal Evaluation of Cytokines in mild cognitive impairment due to AD and Lewy Body Disease2020
Dr Christopher Morris
C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy2019
Dr Christopher Morris
MAPT p.V363I mutation: A rare cause of corticobasal degeneration2019
Dr Michael Keogh
Dr Christopher Morris
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity2019
1234567891011121314151617181920...